Skip to main content

Table 2 Dose-response association between blood lipids and the risk of DKD

From: Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China

Exposure Variables

TG

HDL-C

TG/HDL-C

Non-HDL-C/HDL-C

OR (95%CI)

P

OR (95%CI)

P

OR (95%CI)

P

OR (95%CI)

P

Total

 Turning point

1.90 mmol/L

 

1.62 mmol/L

 

2.00

 

3.09

 

 Lower than turning point

1.48(1.21–1.81)

< 0.001

0.42(0.31–0.58)

< 0.001

1.52(1.30–1.78)

< 0.001

1.34(1.17–1.53)

< 0.001

 Higher than turning point

0.99(0.89–1.09)

0.793

1.68(0.95–2.95)

0.074

0.95(0.87–1.05)

0.316

0.97(0.85–1.10)

0.603

Men

 Turning point

–

 

1.62 mmol/L

 

1.96

 

3.07

 

 Lower than turning point

–

–

0.43(0.27–0.70)

0.001

1.51(1.18–1.95)

0.001

1.40(1.13–1.73)

0.002

 Higher than turning point

–

–

1.15(0.41–3.21)

0.789

0.98(0.87–1.10)

0.715

1.01(0.84–1.22)

0.932

Women

 Turning point

–

 

1.61 mmol/L

 

2.09

 

2.63

 

 Lower than turning point

–

–

0.43(0.28–0.68)

< 0.001

1.59(1.29–1.94)

< 0.001

1.45(1.14–1.85)

0.003

 Higher than turning point

–

–

1.72(0.87–3.39)

0.120

0.88(0.76–1.03)

0.119

0.97(0.84–1.11)

0.620

  1. Adjusted for age, sex, family history of diabetes mellitus, duration of diabetes mellitus, current medical treatment, smoke status, comorbid hypertension, comorbid CAD, comorbid stroke, BMI, HbA1c, SBP